TD Waterhouse Canada’s Can-Fite BioPharma American Depositary Shares CANF Stock Holding History

TD Waterhouse Canada’s Portfolio CANF Stock Details CANF Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4	Hold	1	–	–	﹤0.01%	2387
2026 Q1	$3	Hold	1	–	–	﹤0.01%	2296
2025 Q4	$4	Hold	1	–	–	﹤0.01%	2029
2025 Q3	$12	Hold	1	–	–	﹤0.01%	2045
2025 Q2	$21	Hold	1	–	–	﹤0.01%	1953
2025 Q1	$28	Hold	1	–	–	﹤0.01%	1905
2024 Q4	$32	Hold	1	–	–	﹤0.01%	1927
2024 Q3	$38	Hold	1	–	–	﹤0.01%	1851
2024 Q2	$52	Buy	+1	New	+$47	﹤0.01%	1859
2024 Q1	–	Sell	-1	Closed	-$54	–	1796
2023 Q4	$54	Hold	1	–	–	﹤0.01%	1672
2023 Q3	$67	Hold	1	–	–	﹤0.01%	1671
2023 Q2	$82	Hold	1	–	–	﹤0.01%	1705
2023 Q1	$59	Hold	1	–	–	﹤0.01%	1710
2022 Q4	$164	Hold	1	–	–	﹤0.01%	1653
2022 Q3	$199	Hold	1	–	–	﹤0.01%	1661
2022 Q2	$233	Hold	1	–	–	﹤0.01%	1691
2022 Q1	$303	Hold	1	–	–	﹤0.01%	1726
2021 Q4	$354	Buy	+1	New	+$275	﹤0.01%	1695

Other funds holding CANF

Fifth Third Bancorp Cincinnati, Ohio $61.7B AUM 33.76% 1-Year Est. Return

AWM

Activest Wealth Management Aventure, Florida $518M AUM 44.34% 1-Year Est. Return

TD Waterhouse Canada's CANF Position: Q2 2026 in Review

TD Waterhouse Canada held its Can-Fite BioPharma American Depositary Shares (CANF) position steady in Q2 2026 at 1 share worth $4. The position accounts for ﹤0.01% of the portfolio, ranked #2387.

TD Waterhouse Canada first reported a position in CANF in Q4 2021 and has held it in 18 quarters since. The position peaked at $354 in Q4 2021. 4 funds tracked by Wall St. Rank hold CANF as of Q2 2026.

TD Waterhouse Canada held 1 share of Can-Fite BioPharma American Depositary Shares worth $4 as of Q2 2026.
TD Waterhouse Canada left its Can-Fite BioPharma American Depositary Shares share count unchanged in Q2 2026.
Can-Fite BioPharma American Depositary Shares made up ﹤0.01% of TD Waterhouse Canada's portfolio in Q2 2026, its #2387 holding.
TD Waterhouse Canada first reported a position in Can-Fite BioPharma American Depositary Shares in Q4 2021 and has held it in 18 quarters since.
TD Waterhouse Canada's Can-Fite BioPharma American Depositary Shares position peaked at $354 in Q4 2021.
4 funds tracked by Wall St. Rank held Can-Fite BioPharma American Depositary Shares as of Q2 2026.

Based on TD Waterhouse Canada's 13F filing for Q2 2026, filed 27 Jul 2026.